RFK Jr. pushes for AI-driven health data integration to investigate vaccine safety

Key points

• Kennedy proposed aggregating data from the FDA, CDC, and CMS, including Medicaid and Medicare records, to create a unified health database accessible to external researchers.
• The administration is using AI to analyze data for potential links between vaccines, aluminum adjuvants, and health outcomes like autism, a move Kennedy described as necessary to combat 'medical tyranny.'
• Kennedy criticized the CDC's Vaccine Safety Datalink (VSD) as an 'unworkable system' that previously blocked independent researchers, such as the Geier brothers, from accessing data in the early 2000s.
• The MAHA Institute, led by Mark Gorton, has received $4m in funding from Kennedy through various foundations, raising questions about the independence of the research agenda.
• While Kennedy touted AI's potential, he noted that state-level data remains fragmented, with some states like Arizona requiring individual consent for research use, complicating the federal government's data-sharing goals.

Background

This push for data integration follows a period of internal conflict within the MAHA movement regarding its corporate sponsors and grassroots goals. It also comes after recent disputes over measles death counts in Pennsylvania, where Kennedy and the CDC challenged state-level reporting, highlighting the administration's broader effort to control and reinterpret public health data.

How outlets are covering it

The Guardian and STAT highlight the tension between Kennedy's desire for open data and the privacy concerns raised by experts like Jonathan Ketcham and Andrew Kress, who note that data governance and legal barriers, not just technical ones, prevent such integration. Politico emphasizes Kennedy's framing of AI as a tool to liberate Americans from 'medical tyranny' and expert gatekeeping, while KOMO focuses on his prediction that AI will fundamentally transform medicine. The outlets agree on the scale of the data Kennedy wants to access but differ in their emphasis on the privacy implications versus the political rhetoric surrounding AI.

Why it matters

The proposed integration of health data could lead to significant changes in how vaccine safety and chronic disease research are conducted in the US. If successful, it could provide new evidence on the links between vaccines and autism, a topic that has been highly controversial. However, it also raises serious concerns about patient privacy and the potential for politicized research, as the administration seeks to bypass traditional data governance structures.

What to watch

The administration is expected to continue its efforts to standardize health data and expand AI use in research. The success of the Nebraska model, which shares data with the federal government, may influence other states to follow suit, though legal and privacy hurdles remain significant. The coming months will likely see more debates over the balance between data accessibility and patient privacy.